Abstract: Provided are a hydroxy-terminated siloxane, a polysiloxane-polycarbonate copolymer including same as a repeating unit, and a preparation method thereof. The hydroxyl-terminated siloxane has the structure of chemical formula 1.
Type:
Grant
Filed:
February 23, 2011
Date of Patent:
August 12, 2014
Assignee:
Samyang Corporation
Inventors:
Sun Mi Kim, Jae Hyun Kim, Kyung Moo Shin, Sung Hwan Cho, Whan Gi Kim, Dong Wan Seo
Abstract: The present invention relates to a polyester resin prepared by adding an anti-hydrolysis agent to a reactant comprising an acid selected from an alkylester of aromatic dibasic acid or a mixture of an alkylester of aromatic dibasic acid and an alkylester of aliphatic dibasic acid, an aromatic diol and an aliphatic diol; and a toner produced by using the same as a binder resin.
Type:
Grant
Filed:
October 22, 2010
Date of Patent:
June 11, 2013
Assignee:
Samyang Corporation
Inventors:
Ui Gab Joung, Hyung Jin Roh, Yun Ju Chang, Sung Hwan Cho, Byung Ho Lim
Abstract: Disclosed is a conjugate for gene transfer, which is capable of being used for treatment of incurable diseases, comprising an oligonucleotide intended to be transferred into target cells and a hydrophilic polymer, wherein an end of the oligonucleotide is covalently conjugated to the hydrophilic polymer. Also, the present invention discloses polyelectrolyte complex micelles formed from such a conjugate and a cationic polymer or cationic peptide. Such polyelectrolyte complex micelles can effectively transfer oligonucleotides as therapeutic agents into target cells, making it possible to obtain desired activities of the delivered oligonucleotides in target cells even when the micelles are clinically applied at a relatively low concentration. Therefore, the conjugate and the polyelectrolyte complex micelle are very useful in basic life science research and the medical field.
Type:
Grant
Filed:
April 3, 2003
Date of Patent:
December 4, 2012
Assignees:
Korea Advanced Institute of Science and Technology, Bioneer Corporation, Samyang Corporation
Abstract: Disclosed are an anionic drug-containing pharmaceutical composition comprising: an anionic drug as an active ingredient; a cationic lipid; and an amphiphilic block copolymer, wherein the anionic drug forms a complex with the cationic lipid, and the complex is entrapped in the micelle structure of the amphiphilic block copolymer, and a method for preparing the same. The pharmaceutical composition may increase stability of the anionic drug in blood or in a body fluid, and it may enable intracellular delivery to improve efficacy of anionic drugs.
Type:
Application
Filed:
December 24, 2009
Publication date:
November 3, 2011
Applicant:
SAMYANG CORPORATION
Inventors:
Se-Ho Kim, Ji-Yeon Son, Muhn-Ho La, Sung-Won Choi, Min-Hyo Seo
Abstract: Disclosed is a pharmaceutical composition of a lyophilized formulation including a multiblock copolymer in which two or more ABA-type triblocks are covalently connected through biodegradable dicarboxylic linkage, wherein A represents a polyethylene oxide block and B represents a polypropylene oxide block, a polybutylene oxide block, or a block of copolymer of propylene oxide and butylene oxide, the multiblock copolymer being included in an amount of 1 to 7 wt % based on the total weight of solution prior to the lyophilized formulation. The composition is capable of reducing reconstitution time of a lyophilized sustained-release formulation.
Abstract: Provided is a method for preparing a poorly water-soluble drug-containing polymeric micellar nanoparticle composition, which includes: dissolving a poorly water-soluble drug, a salt of polylactic acid or polylactic acid derivative, whose carboxylic acid end is bound to an alkali metal ion, and an amphiphilic block copolymer into an organic solvent; and adding an aqueous solution to the resultant mixture in the organic solvent to form micelles, wherein the method requires no separate operation to remove the organic solvent prior to the formation of micelles. The method for preparing a poorly water-soluble drug-containing polymeric micellar nanoparticle composition is simple, reduces the processing time, and is amenable to mass production.
Abstract: Provided is a method for preparing a drug-containing polymeric micelle composition, which includes: dissolving a drug and an amphiphilic block copolymer into an organic solvent; and adding an aqueous solution to the resultant mixture in the organic solvent to form polymeric micelles, wherein the method requires no separate operation to remove the organic solvent prior to the formation of micelles. The method for preparing a drug-containing polymeric micelle composition is simple, reduces the processing time, and is amenable to mass production.
Abstract: The present invention relates to a biodegradable branched polylactic acid derivative of formula 1, and preparation method and use thereof: <formula 1> 1-(R—X)n wherein each of X, R, I and n is defined as in the detailed description.
Type:
Grant
Filed:
December 3, 2004
Date of Patent:
September 20, 2011
Assignee:
Samyang Corporation
Inventors:
Min-Hyo Seo, Bong-Oh Kim, In-Ja Choi, Myung-Seob Shim
Abstract: Disclosed is a pharmaceutical composition for release control comprising a plurality of particles for release control. The plurality of particles for release control comprise a core material containing methylphenidate and a polymer coating layer for release control formed on the core material. The plurality of particles for release control are divided into two or more groups based on the average thickness of the polymer coating layer for release control. The particle groups are identical in terms of the composition of the polymer in the polymer coating layer, but are different in terms of the average thickness of the coated layer. The pharmaceutical composition for release control according to the present invention may control the release pattern of methylphenidate contained in the core material as desired, and can be used as an oral formulation in a variety of forms such as orally disintegrating tablets, etc.
Type:
Application
Filed:
November 6, 2009
Publication date:
September 15, 2011
Applicant:
SAMYANG CORPORATION
Inventors:
Sang Yeob Park, Hojin Chung, Chaul Min Pai
Abstract: Disclosed are a polymer micelle composition for treatment of resistant cancer cells that contains an amphiphilic double block copolymer and taxane and a P-glycoprotein inhibitor of cyclosporin as its active ingredients, and a method of preparing the same. Said polymer micelle composition for treatment of cancer resistant cells is accumulated in cancer tissue at high concentrations, and has the advantages that it exhibits superior anti-cancer effects for the cancer cells that have exhibited resistance due to over-expression of P-glycoprotein by the taxane anticancer agent in said cancer tissue, and does not cause hypersensitive reactions due to the use of a solubilizer.
Abstract: Disclosed are a highly purified polylactic acid or a derivative thereof, or a salt thereof, and a method for purifying the same. The polylactic acid or a derivative thereof, or a salt thereof may be applied to various medical and drug carrier systems, or the like.
Abstract: A geogrid using fiber-reinforced polymeric strips and its producing method are disclosed. The geogrid of a lattice shape includes plural longitudinal fiber-reinforced polymeric strips longitudinally arranged in parallel at regular intervals and formed by reinforcing fiber in a thermoplastic polymer resin, and plural lateral fiber-reinforced polymer strip laterally arranged in parallel at regular intervals and formed by reinforcing fiber in a thermoplastic polymer resin. Each longitudinal fiber-reinforced polymer strip has at lease one first contact point crossed with the lateral fiber-reinforced polymer strip on the upper surface and at least one second contact point crossed with the lateral fiber-reinforced polymer strips on the lower surface. The contact points are fixed by welding the longitudinal and lateral fiber-reinforced polymer strips.
Abstract: Disclosed is a transdermal delivery system of multiple adhesive layers having a drug-free adhesive layer as an intermediate layer to control drug delivery rate. The transdermal delivery system enhances transdermal delivery rate in the early stage after application on skin and provides sustained control of the drug delivery rate in the intermediate and later stages. Thus, the drug delivery rate effective for treatment can be controlled in a sustained manner.
Abstract: Polymeric compositions capable of forming stable micelles in an aqueous solution, comprising an amphiphilic block copolymer of a hydrophilic block and a hydrophobic block, and a polylactic acid derivative wherein one end of the polylactic acid is covalently bound to at least one carboxyl group. The carboxyl group of the polylactic acid derivative may be fixed with a di- or tri-valent metal ion, obtained by adding the di- or tri-valent metal ion to the polymeric composition.
Type:
Grant
Filed:
October 17, 2002
Date of Patent:
February 1, 2011
Assignee:
Samyang Corporation
Inventors:
Min-Hyo Seo, Sa-Won Lee, Hee-Jo Kim, Jeong-Kyung Kim, Myung-Han Huyn, Jeong-il Yu, Bong-Oh Kim
Abstract: Disclosed are a highly pure amphiphilic block copolymer including a hydrophobic polymer block of a poly(?-hydroxy acid), and a method for preparing the same. The method for preparing a highly pure amphiphilic block copolymer including a hydrophobic polymer block of a poly(?-hydroxy acid) includes removing ?-hydroxy acid, lactone monomers thereof, oligomers thereof and an organometal catalyst in polymerizing the amphiphilic block copolymer.
Type:
Application
Filed:
December 31, 2008
Publication date:
November 4, 2010
Applicant:
Samyang Corporation
Inventors:
Bong Oh Kim, Myung Seob Shim, Min-Hyo Seo
Abstract: A matrix-type transdermal drug delivery system including capsaicin or a capsaicin derivative as an active component and used for treating neuropathy, pain, and inflammation and a preparation method thereof are provided. The matrix-type transdermal drug delivery system includes: a drug protecting layer; a matrix layer formed on the drug protecting layer and including 0.1-25 wt % of capsaicin or a capsaicin derivative, 40-95 wt % of an adhesive including a water-insoluble acrylic polymer, 1-30 wt % of an alcohol having a molecular weight of 600 Daltons or less, 0.1-20 wt % of a nonionic surfactant, and 0.1-20 wt % of a solubilizing agent including a hydrophilic polymer; and a release liner formed on the matrix layer, and is used for treating neuropathy, pain, or inflammation.
Abstract: An active agent containing adhesive composition suitable for transdermal drug delivery having excellent water absorbability which comprises an effective amount of an active agent, an acrylate adhesive, a polyvinylpyrrolidone having a molecular weight of 1,000,000-5,000,000; a polyvinylpyrrolidone having a molecular weight of 2,000-50,000; a non-ionic surfactant; a terpene; and a dissolution assistant.
Abstract: The present invention relates to an orally administrable composition containing nanoparticles with the particle size of 500 nm or less, comprising 0.1-30 weight % of a complex of a water-soluble drug and a counter-ion substance in which the charged water-soluble drug is bonded with the counter-ion substance, 0.5-80 weight % of a lipid, 0.5-80 weight % of a polymer, and 1-80 weight % of an emulsifier, wherein the weight ratio of said lipid and said polymer is in the range of 1:0.05-3, and a preparation method thereof. The composition of the present invention has high gastrointestinal absorption rate upon oral administration, and has high drug entrapping rate in the nanoparticle, and is also stable against lipases.
Type:
Grant
Filed:
December 24, 2004
Date of Patent:
March 9, 2010
Assignee:
Samyang Corporation
Inventors:
Chaul Min Pai, Mi Hong Min, Jun Seok Hwang, Kyung Mi Cho
Abstract: The present invention relates to an ionic multi-block copolymer composition comprising tri-block copolymers having a polypropyleneoxide or polybutyleneoxide block positioned between two polyethyleneoxide blocks and the tri-block copolymers are connected through dicarboxylic acid linkages forming a multi-block copolymer having a weight average molecular weight of more than 40,000 Dalton. The higher weight average molecular weight enables the hydrolgel formed from the multi-block copolymer of the present invention to maintain its gel status for more than several days.
Type:
Grant
Filed:
August 1, 2005
Date of Patent:
February 2, 2010
Assignee:
Samyang Corporation
Inventors:
Min-Hyo Seo, Bong-Oh Kim, Myung-Seob Shim, Sang-Jun Lee
Abstract: The present invention relates to a nanoparticle composition comprising a camptothecin derivative, solid polyethyleneglycol and an anti-associative agent, and the process for preparing the same. Specifically, the present invention provides a composition comprising a nanoparticle of the camptothecin derivative, which is prepared by solid-dispersing the poorly water soluble camptothecin derivative in polyethyleneglycol and dissolving the solid dispersions in an aqueous solution containing an anti-associative agent. The composition of the present invention stabilizes the camptothecin derivative lactone form in body fluid for effective anticancer activity.
Type:
Application
Filed:
September 20, 2007
Publication date:
January 14, 2010
Applicant:
SAMYANG CORPORATION
Inventors:
Hye Won Kang, Eun Young Yim, Min Hyo Seo